Ozempic maker sues Hims & Hers

(CNN)– Drug maker Novo Nordisk has filed a lawsuit against telehealth provider Hims and Hers over alleged copycat versions of its weight-loss and obesity medications.

The lawsuit, filed Tuesday, Feb. 10, 2026, accuses Hims and Hers of making compounded knock off versions of the popular drugs Ozempic and Wegovy.

Novo Nordisk estimates one and a half million people in the U.S. are using compound versions of its drugs.

When the drugs were in short supply the FDA allowed compounding pharmacies to make similar medications to fill gaps for patients.

But Ozempic and Wegovy were removed from the shortage list last year.